Levenger Launches New Simply Irresistible Line Featuring its Popular Circa® Disc Bound System

Levenger debuts its first undated agenda with refills and dividers in bright, playful and functional designs Levenger, famous for crafting and curating premium products for readers, writers, thinkers, dreamers, and doers, announces the launch of its newest line, Simply Irresistible. The first two collections in the series, Colorfull and Lemonade, are available for purchase. Secret

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Equinix, Inc. (EQIX) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Equinix, Inc. ("Equinix" or "the Company") (NASDAQ:EQIX). Investors who purchased Equinix securities prior to May 3, 2019, and continue to hold to the present, are encouraged to obtain additional

Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amylyx Pharmaceuticals, Inc. ("Amylyx" or "the Company") (NASDAQ:AMLX). Investors who purchased Amylyx securities prior to November 11, 2022, and continue to hold to the present, are encouraged to obtain

Macy’s, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 30, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Macy’s, Inc. ("Macy’s" or "the Company") (NYSE:M) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or

Pharmacy Increases Revenue 52% for Vaccine Delivery Using Workflow Services

Medical billing platform has streamlined patient encounters by automating claim submissions and resolving issues with payors, new case study shows Workflow Services, a turn-key software platform to perform pharmacist-led clinical services, released data today that reveals a 52% pharmacy vaccine revenue increase. The data was collected as part of a case study at a community

Bronstein, Gewirtz & Grossman, LLC Encourages Direct Digital Holdings Inc. (DRCT) Investors to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / January 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Direct Digital Holdings Inc. ("Direct Digital" or "the Company") (NASDAQ:DRCT). Investors who purchased Direct Digital securities prior to April 17, 2023, and continue to hold to the present, are encouraged

Bronstein, Gewirtz & Grossman, LLC Is Investigating Domino’s Pizza, Inc. (DPZ) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / January 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Domino’s Pizza, Inc. ("Domino’s" or "the Company") (NYSE:DPZ). Investors who purchased Domino’s securities prior to December 7, 2023, and continue to hold to the present, are encouraged to obtain

Rapid7, Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach Out

LOS ANGELES, CA / ACCESS Newswire / January 30, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Rapid7, Inc. ("Rapid7" or "the Company") (NASDAQ:RPD) for potential breaches of fiduciary duty on the part of its directors and management. The investigation

Investors With Losses Are Invited To Join The Schall Law Firm In An Investigation Into Zuora, Inc. For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / January 30, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Zuora, Inc. ("Zuora" or "the Company") (NYSE:ZUO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation